Indium and its Compounds Work
Indium and its Compounds Work
Health Hazards
Acute:
Inhalation: 1.1 Can irritate the lungs, causing coughing, chest pain, difficulty breathing, bronchitis, and headaches. 1.2 Irritates eyes, skin, and mucous membranes, with symptoms including burning sensations, pain, nausea, and vomiting.
Eye Contact: Causes eye irritation and may lead to vision damage.
Ingestion: Causes burning sensations, nausea, vomiting, and may result in acute gastroenteritis.
Chronic:
In 2006, IARC classified indium compounds as Group 2A carcinogens. Though human evidence is lacking, studies show increased rates of lung cancer, liver cancer, and pheochromocytoma in rats.
May damage male testicles and female reproductive systems and is considered a teratogen (causing birth defects).
Prolonged exposure may lead to pulmonary fibrosis, with pathological confirmation showing interstitial lung fibrosis and granuloma formation.
Recommendations:
Level 1 Management: No specific regulations.
Level 2-4 Management: Consider exclusion from work for those with respiratory diseases (such as asthma, chronic bronchitis, or emphysema), eye diseases, skin diseases, and pregnant workers for health protection.
Health Hazards
Acute:
Inhalation: 1.1 Can irritate the lungs, causing coughing, chest pain, difficulty breathing, bronchitis, and headaches. 1.2 Irritates eyes, skin, and mucous membranes, with symptoms including burning sensations, pain, nausea, and vomiting.
Eye Contact: Causes eye irritation and may lead to vision damage.
Ingestion: Causes burning sensations, nausea, vomiting, and may result in acute gastroenteritis.
Chronic:
In 2006, IARC classified indium compounds as Group 2A carcinogens. Though human evidence is lacking, studies show increased rates of lung cancer, liver cancer, and pheochromocytoma in rats.
May damage male testicles and female reproductive systems and is considered a teratogen (causing birth defects).
Prolonged exposure may lead to pulmonary fibrosis, with pathological confirmation showing interstitial lung fibrosis and granuloma formation.
Recommendations:
Level 1 Management: No specific regulations.
Level 2-4 Management: Consider exclusion from work for those with respiratory diseases (such as asthma, chronic bronchitis, or emphysema), eye diseases, skin diseases, and pregnant workers for health protection.